Health & Fitness News February 12, 2025 Biogen beats estimates on cost cuts and new drugs like Leqembi, but profit outlook falls short February 12, 2025 CVS shares pop 15% on big earnings beat, even as high medical costs drag down insurance unit February 10, 2025 Trump is unlikely to end Medicare drug price talks — here's what that means for patients and pharma February 7, 2025 Hims & Hers faces scrutiny from senators on Super Bowl ad that 'risks misleading' patients February 7, 2025 Doximity shares pop 36% on revenue beat, rosy guidance February 6, 2025 Alphabet's Verily to sell Granular insurance business to Elevance Health February 6, 2025 Doximity shares soar 25% after company beats on revenue, raises fiscal-year guidance February 6, 2025 Eli Lilly beats on earnings even as weight loss, diabetes drug sales fall short February 6, 2025 Eli Lilly to release late-stage data on next-generation weight loss drug retatrutide in 2025, earlier than expected 1 2 3 4 5 … 12 13 14 15 Next »
February 12, 2025 Biogen beats estimates on cost cuts and new drugs like Leqembi, but profit outlook falls short
February 12, 2025 CVS shares pop 15% on big earnings beat, even as high medical costs drag down insurance unit
February 10, 2025 Trump is unlikely to end Medicare drug price talks — here's what that means for patients and pharma
February 7, 2025 Hims & Hers faces scrutiny from senators on Super Bowl ad that 'risks misleading' patients
February 6, 2025 Doximity shares soar 25% after company beats on revenue, raises fiscal-year guidance
February 6, 2025 Eli Lilly to release late-stage data on next-generation weight loss drug retatrutide in 2025, earlier than expected